Albumin-binding tag derived Exendin-4 analogue for treating hyperglycemia and diabetic complications
Current study was conducted to design and screen a long-lasting Exendin-4 analog for treating type 2 diabetes via the novel strategy of albumin binding combined with thrombin enzymolysis. Firstly, a series of fusion peptides, containing different albumin-binding tags, a determinate thrombin-cleavabl...
Saved in:
Main Authors: | Shujuan Xu, Fang Wang, Hui Li, Ya Wang, Dongzhong Fang |
---|---|
Format: | article |
Language: | EN |
Published: |
Taylor & Francis Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/afad88e87b4d4802b9a0a4bd3de12f00 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Journal of diabetes and its complications
Published: (1992) -
TEMPERATURE EFFECT ON BINDING AFFINITY AND STOICHIOMETRY BETWEEN SOME STEROIDS AND HUMAN SERUM ALBUMIN
by: ÖZDEMÍR,SERKAN, et al.
Published: (2016) -
Evaluación de la anticoagulación con rivaroxaban, en pacientes con fibrilación auricular no valvular de reciente diagnóstico
by: Neira,Víctor, et al.
Published: (2016) -
Glucagon-Like Peptide-1 Agonist Exendin-4 Facilitates the Extinction of Cocaine-Induced Condition Place Preference
by: Changliang Zhu, et al.
Published: (2021) -
Fibrinogen to Albumin Ratio as an Independent Risk Factor for Type 2 Diabetic Kidney Disease
by: Wang K, et al.
Published: (2021)